BREAST CANCER ▲ https://phgkb.cdc.gov/GAPPKB/phgHome.do

https://phgkb.cdc.gov/GAPPKB/phgHome.do?query=Breast Cancer&action=search&Mysubmit=Search




Last Posted: Mar 30, 2017

---

• Facilitating informed decisions about breast cancer screening: development and evaluation of a web-based decision aid for women in their 40s.  
  Elkin Elena B et al. BMC medical informatics and decision making 2017 Mar 17(1) 29
• The Impact of Mental Illness on Uptake of Genetic Counseling for Hereditary Breast Cancer and Ovarian Cancer in a Multiethnic Cohort of Breast Cancer Patients.  
  Ackerman Marra G et al. The breast journal 2017 Mar
• Use of BRCA Mutation Test in the U.S., 2004-2014.  
  Guo Fangjian et al. American journal of preventive medicine 2017 Mar
• Breast cancer and genomic testing.  
  Liedtke C et al. The British journal of surgery 2017 Mar
• Genetic anticipation in BRCA1/BRCA2 families after controlling for ascertainment bias and cohort effect.  
  Guindalini Rodrigo Santa Cruz et al. Cancer 2016 122(12) 1913-20
• Risk of breast cancer after a diagnosis of ovarian cancer in BRCA mutation carriers: Is preventive mastectomy warranted?  
  McGee Jacob et al. Gynecologic oncology 2017 Mar
• The effect of a celebrity health disclosure on demand for health care: trends in BRCA testing and subsequent health services use.  
  Roberts Megan C et al. Journal of community genetics 2017 Mar
• Evolving Trends and Influencing Factors in Mastectomy Decisions.  
  Bhat Sneha et al. The American surgeon 2017 Mar 83(3) 233-238
• Association of Polymorphisms in FCGR2A and FCGR3A With Degree of Trastuzumab Benefit in the Adjuvant Treatment of ERBB2/HER2–Positive Breast Cancer Analysis of the NSABP B-31 Trial  
  PG Gavin et al, JAMA Oncology, March 2017
• Predictive Value of FcR Polymorphisms A Further Step on the Long and Winding Road to Application  
  R Dolcetti, JAMA Oncology, March 2017
• Preparing young people for future decision-making about cancer risk in families affected or at risk from hereditary breast cancer: A qualitative interview study.  
  Rowland Emma et al. European journal of oncology nursing : the official journal of European Oncology Nursing Society 2016 Dec 259-15
• Prediction of years of life after diagnosis of breast cancer using omics and omic-by-treatment interactions  
  Agustín González-Reymúndez et al, Eur J Human Genetics, March 8, 2017
• Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM).  
  Duffy M J et al. European journal of cancer (Oxford, England : 1990) 2017 Feb 75284-298
• Prediction of years of life after diagnosis of breast cancer using omics and omic-by-treatment interactions  
  Agustín González-Reymúndez et al, Eur J Human Genetics, March 8, 2017
• Using lessons from breast, cervical, and colorectal cancer screening to inform the development of lung cancer screening programs.  
  Armstrong Katrina et al. Cancer 2016 122(9) 1338-42
• [Genetic Counseling of HBOC and Japanese Organization of HBOC].  
  Fukushima Yoshimitsu et al. Gan to kagaku ryoho. Cancer & chemotherapy 2017 Feb 44(2) 107-110

more